$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
When will Lumakras (sotorasib) be available in China? What disease is treated?
2025-10-19 11:44:20
Check Details
What kind of people are suitable for using Lumakras? What are the precautions for using Lumakras
2025-10-19 11:44:20
Check Details
[News Flash] Lumakras, the first KRAS-targeting drug for lung cancer, is approved by the FDA for marketing
2025-10-19 11:44:20
Check Details
How much does a box of Lumakras cost in 2021? Where can I buy imported Lumakras cheaper?
2025-10-19 11:44:20
Check Details
How long does it take for resistance to icotinib to develop? What are the symptoms of icotinib resistance?
2025-10-19 11:44:20
Check Details
How much does a box of the new lung cancer drug Icotinib cost? Can the targeted drug icotinib be purchased in domestic pharmacies?
2025-10-19 11:44:20
Check Details
Nivolumab/ipilimumab combination chemotherapy can treat advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
CLN-081 shows anti-tumor activity in first-in-human trial for treatment of mutation-positive non-small cell lung cancer_Canghule
2025-10-19 11:44:20
Check Details
Rybrevant, the first targeted therapy for refractory lung cancer, is here
2025-10-19 11:44:20
Check Details
Rybrevant, a new drug for non-small cell lung cancer, was approved for marketing, and when Rybrevant will be launched
2025-10-19 11:44:20
Check Details
Has the imported drug topotecan been approved for marketing in the country? Where can I buy topotecan?
2025-10-19 11:44:20
Check Details
[Drug Analysis] What is the difference between topotecan and irinotecan?
2025-10-19 11:44:20
Check Details
1
2
...
3938
3939
3940
3941
3942
3943
3944
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
2
Vemurafenib (Zelboraf) Complete Medication Guide
3
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
4
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
5
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
6
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
7
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
8
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
9
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth
10
Tofacitinib: The Role and Considerations of an Oral JAK Inhibitor in Autoimmune Disease Treatment
11
Tucatinib: Redefining the Treatment Landscape for HER2-Positive Cancers with High Selectivity
12
Complete Guide to Garsorasib Resistance Mechanisms and Follow-Up Treatments